TreeWAS – Variant ID: rs809736

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C91.1 Chronic lymphocytic leukaemia	0.077	0.923	0.000
C91 Lymphoid leukaemia	0.065	0.935	0.000
C91.4 Hairy-cell leukaemia	0.058	0.942	0.000
C91.0 Acute lymphoblastic leukaemia	0.057	0.943	0.000
C91.9 Lymphoid leukaemia, unspecified	0.051	0.949	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.047	0.953	0.000
C91.7 Other lymphoid leukaemia	0.047	0.953	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.047	0.953	0.000
C91.3 Prolymphocytic leukaemia	0.047	0.953	0.000
C91.2 Subacute lymphocytic leukaemia	0.047	0.953	0.000
C91.5 Adult T-cell leukaemia	0.045	0.955	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.029	0.971	0.000
Z85.2 Personal history of malignant neoplasm of other respiratory and intrathoracic organs	0.000	0.977	0.023
M79.0 Rheumatism, unspecified	0.022	0.978	0.000
T39.0 Salicylates	0.000	0.979	0.021
M79.00 Rheumatism, unspecified (Multiple sites)	0.020	0.980	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.982	0.018
M79.01 Rheumatism, unspecified (Shoulder region)	0.018	0.982	0.000
M79.08 Rheumatism, unspecified (Other)	0.017	0.983	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.984	0.016
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.984	0.016
M79.07 Rheumatism, unspecified (Ankle and foot)	0.016	0.984	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.016	0.984	0.000
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.016	0.984	0.000
M79.04 Rheumatism, unspecified (Hand)	0.016	0.984	0.000
M79.03 Rheumatism, unspecified (Forearm)	0.016	0.984	0.000
M79.02 Rheumatism, unspecified (Upper arm)	0.016	0.984	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.984	0.016
T45.5 Anticoagulants	0.000	0.985	0.015
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.985	0.015
T45.0 Antiallergic and antiemetic drugs	0.000	0.985	0.014
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.986	0.014
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.986	0.014
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.986	0.014
C22.9 Liver, unspecified	0.013	0.987	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.987	0.013
T39.4 Antirheumatics, not elsewhere classified	0.000	0.987	0.013
T39.2 Pyrazolone derivatives	0.000	0.987	0.013
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.987	0.013
C22.0 Liver cell carcinoma	0.013	0.987	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.013	0.987	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.988	0.012
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.988	0.012
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.988	0.012
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.988	0.012
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.988	0.012
T45.8 Other primarily systemic and haematological agents	0.000	0.988	0.012
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.988	0.012
T45.6 Fibrinolysis-affecting drugs	0.000	0.988	0.012
T45.4 Iron and its compounds	0.000	0.988	0.012
T45.3 Enzymes, not elsewhere classified	0.000	0.988	0.012
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.988	0.012
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.988	0.012
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.988	0.011
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.988	0.011
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.989	0.011
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.989	0.011
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.989	0.011
T36 Poisoning by systemic antibiotics	0.000	0.989	0.011
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.989	0.010
T50.8 Diagnostic agents	0.000	0.989	0.010
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.989	0.010
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.989	0.010
T46.7 Peripheral vasodilators	0.000	0.989	0.010
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.989	0.010
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.989	0.010
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.989	0.010
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.990	0.010
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.990	0.010
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.990	0.010
T38.9 Other and unspecified hormone antagonists	0.000	0.990	0.010
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.990	0.010
T38.7 Androgens and anabolic congeners	0.000	0.990	0.010
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.990	0.010
T38.5 Other oestrogens and progestogens	0.000	0.990	0.010
T38.4 Oral contraceptives	0.000	0.990	0.010
T38.2 Antithyroid drugs	0.000	0.990	0.010
T38.0 Glucocorticoids and synthetic analogues	0.000	0.990	0.010
T50.7 Analeptics and opioid receptor antagonists	0.000	0.990	0.010
T50.5 Appetite depressants	0.000	0.990	0.010
T50.4 Drugs affecting uric acid metabolism	0.000	0.990	0.010
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.990	0.010
T50.1 Loop [high-ceiling] diuretics	0.000	0.990	0.010
T50.0 Mineralocorticoids and their antagonists	0.000	0.990	0.010
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.990	0.010
T45.2 Vitamins, not elsewhere classified	0.000	0.990	0.010
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.990	0.009
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.990	0.009
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.990	0.009
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.990	0.009
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.990	0.009
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.990	0.009
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.990	0.009
T44.0 Anticholinesterase agents	0.000	0.990	0.009
C22.1 Intrahepatic bile duct carcinoma	0.010	0.990	0.000
T46.1 Calcium-channel blockers	0.000	0.990	0.009
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.991	0.009
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.991	0.009
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.991	0.009
C22.7 Other specified carcinomas of liver	0.009	0.991	0.000
C22.4 Other sarcomas of liver	0.009	0.991	0.000
C22.3 Angiosarcoma of liver	0.009	0.991	0.000
C22.2 Hepatoblastoma	0.009	0.991	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.991	0.009
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.991	0.009
T37.5 Antiviral drugs	0.000	0.991	0.009
T37.4 Anthelminthics	0.000	0.991	0.009
T37.3 Other antiprotozoal drugs	0.000	0.991	0.009
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.991	0.009
T37.1 Antimycobacterial drugs	0.000	0.991	0.009
T37.0 Sulphonamides	0.000	0.991	0.009
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.991	0.009
T43.6 Psychostimulants with abuse potential	0.000	0.991	0.009
T42.1 Iminostilbenes	0.000	0.991	0.009
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.991	0.009
C25.9 Pancreas, unspecified	0.009	0.991	0.000
T41.5 Therapeutic gases	0.000	0.991	0.008
T41.4 Anaesthetic, unspecified	0.000	0.991	0.008
T41.3 Local anaesthetics	0.000	0.991	0.008
T41.2 Other and unspecified general anaesthetics	0.000	0.991	0.008
T41.1 Intravenous anaesthetics	0.000	0.991	0.008
T41.0 Inhaled anaesthetics	0.000	0.991	0.008
C25 Malignant neoplasm of pancreas	0.009	0.991	0.000
Z36.8 Other antenatal screening	0.000	0.991	0.009
T38.1 Thyroid hormones and substitutes	0.000	0.991	0.008
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.992	0.008
T48.5 Anti-common-cold drugs	0.000	0.992	0.008
T48.4 Expectorants	0.000	0.992	0.008
T48.3 Antitussives	0.000	0.992	0.008
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.992	0.008
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.992	0.008
T48.0 Oxytocic drugs	0.000	0.992	0.008
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.992	0.008
T43.9 Psychotropic drug, unspecified	0.000	0.992	0.008
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.992	0.008
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.992	0.008
Z36 Antenatal screening	0.000	0.992	0.008
T36.9 Systemic antibiotic, unspecified	0.000	0.992	0.008
T36.8 Other systemic antibiotics	0.000	0.992	0.008
T36.7 Antifungal antibiotics, systemically used	0.000	0.992	0.008
T36.6 Rifamycins	0.000	0.992	0.008
T36.5 Aminoglycosides	0.000	0.992	0.008
T36.4 Tetracyclines	0.000	0.992	0.008
T36.3 Macrolides	0.000	0.992	0.008
T36.2 Chloramphenicol group	0.000	0.992	0.008
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.992	0.008
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.992	0.008
M25.51 Pain in joint (Shoulder region)	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.000	0.992	0.008
T49.8 Other topical agents	0.000	0.992	0.008
T49.7 Dental drugs, topically applied	0.000	0.992	0.008
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.992	0.008
T49.5 Ophthalmological drugs and preparations	0.000	0.992	0.008
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.992	0.008
T49.3 Emollients, demulcents and protectants	0.000	0.992	0.008
T49.2 Local astringents and local detergents	0.000	0.992	0.008
T49.1 Antipruritics	0.000	0.992	0.008
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.992	0.008
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.992	0.008
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.992	0.008
T42.3 Barbiturates	0.000	0.992	0.008
T42.2 Succinimides and oxazolidinediones	0.000	0.992	0.008
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.992	0.008
C32.0 Glottis	0.000	0.992	0.008
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.992	0.007
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.992	0.007
T47.7 Emetics	0.000	0.992	0.007
T47.6 Antidiarrhoeal drugs	0.000	0.992	0.007
T47.5 Digestants	0.000	0.992	0.007
T47.4 Other laxatives	0.000	0.992	0.007
T47.3 Saline and osmotic laxatives	0.000	0.992	0.007
T47.2 Stimulant laxatives	0.000	0.992	0.007
T47.0 Histamine H(2)-receptor antagonists	0.000	0.992	0.007
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.992	0.008
C25.0 Head of pancreas	0.008	0.992	0.000
T42.0 Hydantoin derivatives	0.000	0.992	0.007
C15-C26 Malignant neoplasms of digestive organs	0.007	0.993	0.000
C25.2 Tail of pancreas	0.007	0.993	0.000
T36.0 Penicillins	0.000	0.993	0.007
C16 Malignant neoplasm of stomach	0.007	0.993	0.000
C25.8 Overlapping lesion of pancreas	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.993	0.007
C25.3 Pancreatic duct	0.007	0.993	0.000
C16.8 Overlapping lesion of stomach	0.007	0.993	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.993	0.007
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.993	0.007
C16.5 Lesser curvature of stomach, unspecified	0.007	0.993	0.000
C16.9 Stomach, unspecified	0.007	0.993	0.000
T40.6 Other and unspecified narcotics	0.000	0.993	0.006
C25.4 Endocrine pancreas	0.006	0.993	0.000
C21 Malignant neoplasm of anus and anal canal	0.006	0.994	0.000
T43.2 Other and unspecified antidepressants	0.000	0.994	0.006
C25.7 Other parts of pancreas	0.006	0.994	0.000
C17 Malignant neoplasm of small intestine	0.006	0.994	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.994	0.006
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.994	0.006
Z36.5 Antenatal screening for isoimmunisation	0.000	0.994	0.006
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.994	0.006
T40.8 Lysergide [LSD]	0.000	0.994	0.006
T40.7 Cannabis (derivatives)	0.000	0.994	0.006
T40.5 Cocaine	0.000	0.994	0.006
T40.3 Methadone	0.000	0.994	0.006
T40.0 Opium	0.000	0.994	0.006
Y44.2 Anticoagulants	0.000	0.994	0.006
C21.8 Overlapping lesion of rectum, anus and anal canal	0.006	0.994	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.006	0.994	0.000
C16.6 Greater curvature of stomach, unspecified	0.006	0.994	0.000
C25.1 Body of pancreas	0.006	0.994	0.000
C23 Malignant neoplasm of gallbladder	0.006	0.994	0.000
C50.5 Lower-outer quadrant of breast	0.006	0.994	0.000
C16.3 Pyloric antrum	0.005	0.995	0.000
C21.1 Anal canal	0.005	0.995	0.000
C17.2 Ileum	0.005	0.995	0.000
C16.1 Fundus of stomach	0.005	0.995	0.000
T40.1 Heroin	0.000	0.995	0.005
C16.4 Pylorus	0.005	0.995	0.000
A09.9 Gastroenteritis and colitis of unspecified origin	0.000	0.995	0.005
C17.9 Small intestine, unspecified	0.005	0.995	0.000
C16.2 Body of stomach	0.005	0.995	0.000
C32 Malignant neoplasm of larynx	0.000	0.995	0.005
C26 Malignant neoplasm of other and ill-defined digestive organs	0.005	0.995	0.000
T40.4 Other synthetic narcotics	0.000	0.995	0.005
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.005	0.995	0.000
C21.2 Cloacogenic zone	0.005	0.995	0.000
K63.2 Fistula of intestine	0.000	0.995	0.005
C17.8 Overlapping lesion of small intestine	0.005	0.995	0.000
C17.3 Meckel's diverticulum	0.005	0.995	0.000
C32.9 Larynx, unspecified	0.000	0.995	0.005
C17.1 Jejunum	0.005	0.995	0.000
K50.8 Other Crohn's disease	0.005	0.995	0.000
C17.0 Duodenum	0.004	0.996	0.000
C24.0 Extrahepatic bile duct	0.004	0.996	0.000
C21.0 Anus, unspecified	0.004	0.996	0.000
Z80.5 Family history of malignant neoplasm of urinary tract	0.004	0.996	0.000
D47.1 Chronic myeloproliferative disease	0.004	0.996	0.000
C32.8 Overlapping lesion of larynx	0.000	0.996	0.004
C32.3 Laryngeal cartilage	0.000	0.996	0.004
C32.2 Subglottis	0.000	0.996	0.004
C32.1 Supraglottis	0.000	0.996	0.004
C26.8 Overlapping lesion of digestive system	0.004	0.996	0.000
C26.1 Spleen	0.004	0.996	0.000
C24.8 Overlapping lesion of biliary tract	0.004	0.996	0.000
C26.0 Intestinal tract, part unspecified	0.004	0.996	0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.996	0.004
M47.80 Other spondylosis (Multiple sites in spine)	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.996	0.004
T40.2 Other opioids	0.000	0.996	0.004
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.996	0.004
K59.9 Functional intestinal disorder, unspecified	0.003	0.997	0.000
C20 Malignant neoplasm of rectum	0.003	0.997	0.000
C24.9 Biliary tract, unspecified	0.003	0.997	0.000
C26.9 Ill-defined sites within the digestive system	0.003	0.997	0.000
K74.3 Primary biliary cirrhosis	0.003	0.997	0.000
T42.4 Benzodiazepines	0.000	0.997	0.003
C15 Malignant neoplasm of oesophagus	0.003	0.997	0.000
C24.1 Ampulla of Vater	0.003	0.997	0.000
K81.9 Cholecystitis, unspecified	0.000	0.997	0.003
J80 Adult respiratory distress syndrome	0.003	0.997	0.000
I72.3 Aneurysm of iliac artery	0.000	0.997	0.003
C16.0 Cardia	0.003	0.997	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.003	0.997	0.000
K75 Other inflammatory liver diseases	0.003	0.997	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.997	0.003
S00.8 Superficial injury of other parts of head	0.003	0.997	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.997	0.003
K75.9 Inflammatory liver disease, unspecified	0.003	0.997	0.000
K74 Fibrosis and cirrhosis of liver	0.003	0.997	0.000
K75.8 Other specified inflammatory liver diseases	0.003	0.997	0.000
K75.0 Abscess of liver	0.003	0.997	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.997	0.003
K50 Crohn's disease [regional enteritis]	0.003	0.997	0.000
K74.6 Other and unspecified cirrhosis of liver	0.003	0.997	0.000
C15.4 Middle third of oesophagus	0.002	0.997	0.000
Z93.0 Tracheostomy status	0.000	0.997	0.002
K50.0 Crohn's disease of small intestine	0.002	0.998	0.000
C15.3 Upper third of oesophagus	0.002	0.998	0.000
C15.8 Overlapping lesion of oesophagus	0.002	0.998	0.000
C15.2 Abdominal part of oesophagus	0.002	0.998	0.000
C15.1 Thoracic part of oesophagus	0.002	0.998	0.000
C15.0 Cervical part of oesophagus	0.002	0.998	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.002	0.998	0.000
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.000	0.998	0.002
D23.5 Skin of trunk	0.002	0.998	0.000
K75.2 Nonspecific reactive hepatitis	0.002	0.998	0.000
K75.1 Phlebitis of portal vein	0.002	0.998	0.000
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.002	0.998	0.000
C95.9 Leukaemia, unspecified	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.998	0.002
T86.8 Failure and rejection of other transplanted organs and tissues	0.002	0.998	0.000
Z80.6 Family history of leukaemia	0.002	0.998	0.000
R90.0 Intracranial space-occupying lesion	0.000	0.998	0.002
K50.9 Crohn's disease, unspecified	0.002	0.998	0.000
K74.4 Secondary biliary cirrhosis	0.002	0.998	0.000
K74.2 Hepatic fibrosis with hepatic sclerosis	0.002	0.998	0.000
K74.1 Hepatic sclerosis	0.002	0.998	0.000
K70-K77 Diseases of liver	0.002	0.998	0.000
M94.88 Other specified disorders of cartilage (Other)	0.000	0.998	0.002
C95.0 Acute leukaemia of unspecified cell type	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
L29.9 Pruritus, unspecified	0.002	0.998	0.000
Z80 Family history of malignant neoplasm	0.002	0.998	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.002	0.998	0.000
K73 Chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
A08.4 Viral intestinal infection, unspecified	0.000	0.998	0.002
Z80.8 Family history of malignant neoplasm of other organs or systems	0.002	0.998	0.000
I84.3 External thrombosed haemorrhoids	0.002	0.998	0.000
N60.1 Diffuse cystic mastopathy	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.001	0.998	0.001
Z80.3 Family history of malignant neoplasm of breast	0.002	0.998	0.000
G81.9 Hemiplegia, unspecified	0.000	0.998	0.002
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.998	0.002
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.998	0.002
I72 Other aneurysm	0.000	0.998	0.002
K73.9 Chronic hepatitis, unspecified	0.002	0.998	0.000
K74.0 Hepatic fibrosis	0.002	0.998	0.000
W10.8 Other specified place	0.002	0.998	0.000
I72.4 Aneurysm of artery of lower extremity	0.000	0.998	0.002
I61 Intracerebral haemorrhage	0.000	0.998	0.002
K73.2 Chronic active hepatitis, not elsewhere classified	0.002	0.998	0.000
K76 Other diseases of liver	0.002	0.998	0.000
H60.1 Cellulitis of external ear	0.000	0.998	0.002
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.998	0.002
I72.9 Aneurysm of unspecified site	0.000	0.998	0.002
S62.50 Fracture of thumb (closed)	0.002	0.998	0.000
Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs	0.002	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.998	0.002
I72.8 Aneurysm of other specified arteries	0.000	0.998	0.002
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.998	0.002
Z80.4 Family history of malignant neoplasm of genital organs	0.002	0.998	0.000
K77 Liver disorders in diseases classified elsewhere	0.002	0.998	0.000
K71 Toxic liver disease	0.002	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.002	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.002	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.002	0.998	0.000
M94.8 Other specified disorders of cartilage	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.000	0.998	0.002
K73.8 Other chronic hepatitis, not elsewhere classified	0.002	0.998	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.002	0.998	0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.002	0.998	0.000
K76.9 Liver disease, unspecified	0.002	0.998	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
K76.8 Other specified diseases of liver	0.002	0.998	0.000
K76.7 Hepatorenal syndrome	0.002	0.998	0.000
X41.9 Unspecified place	0.000	0.998	0.002
I69.0 Sequelae of subarachnoid haemorrhage	0.000	0.998	0.002
K76.1 Chronic passive congestion of liver	0.002	0.998	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
I61.8 Other intracerebral haemorrhage	0.000	0.998	0.002
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.998	0.002
I65.2 Occlusion and stenosis of carotid artery	0.002	0.998	0.000
K74.5 Biliary cirrhosis, unspecified	0.001	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.002	0.998	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.998	0.002
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.998	0.002
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.000	0.998	0.002
M47.12 Other spondylosis with myelopathy (Cervical region)	0.002	0.998	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
D47.4 Osteomyelofibrosis	0.002	0.998	0.000
D72.8 Other specified disorders of white blood cells	0.002	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.002	0.998	0.000
G81.1 Spastic hemiplegia	0.000	0.998	0.002
K76.5 Hepatic veno-occlusive disease	0.001	0.998	0.000
K76.4 Peliosis hepatis	0.001	0.998	0.000
K76.3 Infarction of liver	0.001	0.998	0.000
K76.2 Central haemorrhagic necrosis of liver	0.001	0.998	0.000
L89.2 Stage III decubitus ulcer	0.000	0.998	0.002
C93 Monocytic leukaemia	0.002	0.998	0.000
R74.8 Abnormal levels of other serum enzymes	0.000	0.998	0.002
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.998	0.001
K50.1 Crohn's disease of large intestine	0.002	0.998	0.000
K71.9 Toxic liver disease, unspecified	0.001	0.998	0.000
K71.8 Toxic liver disease with other disorders of liver	0.001	0.998	0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.001	0.998	0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.001	0.998	0.000
K71.5 Toxic liver disease with chronic active hepatitis	0.001	0.998	0.000
K71.4 Toxic liver disease with chronic lobular hepatitis	0.001	0.998	0.000
K71.3 Toxic liver disease with chronic persistent hepatitis	0.001	0.998	0.000
K71.2 Toxic liver disease with acute hepatitis	0.001	0.998	0.000
K71.1 Toxic liver disease with hepatic necrosis	0.001	0.998	0.000
K71.0 Toxic liver disease with cholestasis	0.001	0.998	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.001	0.998	0.000
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
K72 Hepatic failure, not elsewhere classified	0.002	0.998	0.000
L89 Decubitus ulcer	0.000	0.998	0.002
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.002	0.998	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.998	0.001
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.998	0.001
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.998	0.001
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.998	0.001
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.998	0.001
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.998	0.001
I72.2 Aneurysm of renal artery	0.000	0.998	0.001
L89.3 Stage IV decubitus ulcer	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.001
Y44.7 Plasma substitutes	0.000	0.998	0.001
Y44.6 Natural blood and blood products	0.000	0.998	0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.998	0.001
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.001
A08 Viral and other specified intestinal infections	0.000	0.998	0.002
H60 Otitis externa	0.000	0.998	0.002
C93.1 Chronic monocytic leukaemia	0.001	0.998	0.000
D86.0 Sarcoidosis of lung	0.000	0.998	0.002
H60.3 Other infective otitis externa	0.000	0.998	0.002
H02.0 Entropion and trichiasis of eyelid	0.000	0.998	0.002
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.998	0.001
N60.4 Mammary duct ectasia	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.001
S72.40 Fracture of lower end of femur (closed)	0.002	0.998	0.000
I72.1 Aneurysm of artery of upper extremity	0.000	0.998	0.001
I72.0 Aneurysm of carotid artery	0.000	0.998	0.001
S01.7 Multiple open wounds of head	0.002	0.998	0.000
S70.0 Contusion of hip	0.002	0.998	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.001	0.998	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.001	0.998	0.000
W13.9 Unspecified place	0.001	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.998	0.000
C94 Other leukaemias of specified cell type	0.001	0.998	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.998	0.001
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.999	0.001
C92 Myeloid leukaemia	0.001	0.999	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.999	0.001
K70.4 Alcoholic hepatic failure	0.001	0.999	0.000
M10.07 Idiopathic gout (Ankle and foot)	0.001	0.999	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.001	0.999	0.000
C93.9 Monocytic leukaemia, unspecified	0.001	0.999	0.000
C93.7 Other monocytic leukaemia	0.001	0.999	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.001	0.999	0.000
C93.2 Subacute monocytic leukaemia	0.001	0.999	0.000
C93.0 Acute monocytic leukaemia	0.001	0.999	0.000
M93.9 Osteochondropathy, unspecified	0.000	0.999	0.001
C86 Other specified types of T/NK-cell lymphoma	0.001	0.999	0.000
G81 Hemiplegia	0.000	0.999	0.001
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.999	0.001
H60.4 Cholesteatoma of external ear	0.000	0.999	0.001
Y44.5 Thrombolytic drugs	0.000	0.999	0.001
A08.5 Other specified intestinal infections	0.000	0.999	0.001
A08.2 Adenoviral enteritis	0.000	0.999	0.001
A08.0 Rotaviral enteritis	0.000	0.999	0.001
H60.2 Malignant otitis externa	0.000	0.999	0.001
K72.9 Hepatic failure, unspecified	0.001	0.999	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.999	0.001
Z00.6 Examination for normal comparison and control in clinical research programme	0.001	0.999	0.000
M79.19 Myalgia (Site unspecified)	0.001	0.999	0.000
A08.3 Other viral enteritis	0.000	0.999	0.001
K72.1 Chronic hepatic failure	0.001	0.999	0.000
N48.4 Impotence of organic origin	0.000	0.999	0.001
M79.70 Fibromyalgia (Multiple sites)	0.001	0.999	0.000
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.999	0.001
K76.6 Portal hypertension	0.001	0.999	0.000
D69 Purpura and other haemorrhagic conditions	0.001	0.999	0.000
C94.7 Other specified leukaemias	0.001	0.999	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.999	0.000
C94.5 Acute myelofibrosis	0.001	0.999	0.000
C94.4 Acute panmyelosis	0.001	0.999	0.000
C94.3 Mast cell leukaemia	0.001	0.999	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.999	0.000
C94.1 Chronic erythraemia	0.001	0.999	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.999	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
C96.8 Histiocytic sarcoma	0.001	0.999	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.999	0.000
C96.3 True histiocytic lymphoma	0.001	0.999	0.000
C96.2 Malignant mast cell tumour	0.001	0.999	0.000
C96.1 Malignant histiocytosis	0.001	0.999	0.000
C96.0 Letterer-Siwe disease	0.001	0.999	0.000
D69.2 Other nonthrombocytopenic purpura	0.001	0.999	0.000
G91.2 Normal-pressure hydrocephalus	0.000	0.999	0.001
K82.4 Cholesterolosis of gallbladder	0.001	0.999	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.000	0.999	0.001
N99.0 Postprocedural renal failure	0.001	0.999	0.000
O12.0 Gestational oedema	0.000	0.999	0.001
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.001	0.999	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.001	0.999	0.000
C92.5 Acute myelomonocytic leukaemia	0.001	0.999	0.000
C92.3 Myeloid sarcoma	0.001	0.999	0.000
C92.2 Subacute myeloid leukaemia	0.001	0.999	0.000
Z74.0 Reduced mobility	0.000	0.999	0.001
C88 Malignant immunoproliferative diseases	0.001	0.999	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
H60.0 Abscess of external ear	0.000	0.999	0.001
D51 Vitamin B12 deficiency anaemia	0.000	0.999	0.001
C92.7 Other myeloid leukaemia	0.001	0.999	0.000
D26.1 Corpus uteri	0.001	0.999	0.000
H02.9 Disorder of eyelid, unspecified	0.000	0.999	0.001
W13.4 Street and highway	0.001	0.999	0.000
Z03.3 Observation for suspected nervous system disorder	0.001	0.999	0.000
M94 Other disorders of cartilage	0.000	0.999	0.001
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.999	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.999	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.999	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.999	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations